A Pilot Study of Adcetris Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Scleroderma)
Phase of Trial: Phase II
Latest Information Update: 28 May 2019
Price : $35 *
At a glance
- Drugs Brentuximab vedotin (Primary) ; Azathioprine; Cyclophosphamide; Methotrexate; Mycophenolate mofetil; Mycophenolic acid
- Indications Diffuse scleroderma
- Focus Therapeutic Use
- 22 May 2019 Status changed from not yet recruiting to recruiting.
- 28 Feb 2019 Planned End Date changed from 1 Jun 2019 to 1 Jul 2021.
- 28 Feb 2019 Planned primary completion date changed from 1 Nov 2018 to 1 Mar 2021.